期刊文献+

选择性半肝血流阻断在肝癌半肝切除术中的应用研究 被引量:15

Study on application of selective hemihepatic vascular control in hemihepatectomy for hepatoma
暂未订购
导出
摘要 目的探讨选择性半肝血流阻断在肝癌半肝切除术中的临床价值及安全性。方法将54例行半肝切除术的肝癌患者分为两组:HVC组30例,行选择性半肝血流阻断(HVC法),Pringle组24例,行第一肝门阻断(Pringle法),比较两种方法对术中失血量、手术时间、术后肝功能及并发症发生率等指标的影响。结果两组患者均顺利完成手术。两组失血量、手术时间相比,差异无显著性(P>0.05)。两组肝功能指标、并发症发生率相比,差异有统计学意义(P<0.05)。结论肝癌半肝切除术中采用选择性半肝血流阻断能安全有效地控制术中出血,减少术后并发症,有利于术后肝功能的恢复。 [Objective] To explore the clinical significance and safety of selective hemihepatic vascular control in hemihepatectomy for hepatoma. [Methods] 54 patients with hepatoma who underwent hemihepatectomy were divided into two groups: in group HVC 30 cases underwent hemihepa tic vascular control(HVC) and in group Pringle 24 cases underwent the first hepatic portal control (Pringle). Subsequently, the influence of the two approaches on the parameters including intraoperative blood loss, operative duration, postoperative hepatic function and complications incidence rate was comparatively analyzed. [Results] Hemihepatcctomy was successfully performed in the two groups. There was no significant difference between the two groups in intraoperative blood loss (P 〉0.05). Significant difference existed between the two groups in serum alanine transaminase (ALT) (P 〈0.05). [Conclusions] Selective hemihepatic vascular control (HVC) can be applied to control intraoperative bleeding safely and effectively, reduce complications incidence rate and profit the recovery of postoperative hepatic function parameters.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第15期2331-2333,共3页 China Journal of Modern Medicine
关键词 肝癌 半肝切除 半肝血流阻断 第一肝门阻断 hepatoma hemihepatectomy hemihepatic vascular control the In'st hepatic portal control
  • 相关文献

参考文献3

二级参考文献21

  • 1吴孟超,陈汉,张晓华,姚晓平,杨甲梅.外科治疗原发性肝癌1102例[J].第二军医大学学报,1993,14(3):201-204. 被引量:23
  • 2梁力建,赖佳明,黄洁夫.单侧入肝血流选择性阻断肝切除术(附20例报告)[J].中国实用外科杂志,1996,16(3):146-147. 被引量:10
  • 3刘鹏熙,吕新生,韩明,蔡宏伟.肝门阻断后细菌及内毒素移位的研究[J].中华实验外科杂志,1997,14(1):32-33. 被引量:37
  • 4[1]ZHOU Y J,WANG ZY.Diagnosis and treatment of exogenie liver cancer[J].Zhonggno Xiandai Yixue Zazhi 2002,12(2):55-56.Chinese
  • 5[2]CHENG XP,WU ZD,QIU FZ.Experience of resection of giant liver cancerlin 17 cases[J].Zhonghua Waike Zazhi,2000,1:6-9.Chinese
  • 6[3]Tani M,Edamoto Y,Kawai S,et al.Results of 90 consecutive hepatectomies for hepatoeellular carcinoma:a multivariate analysis of survival[J].Semin Oneol,1997,24:1-6.
  • 7[4]MA ZC,HONG LW,TANG ZY,et al.Third class radical resection standard of primary hepatoeellular carcinoma [J].Zhonghua Zhongliu Zazhi,2004,26(1):33-35.Chinese
  • 8[5]Kirchoff T,Chavan A,Galanski M.Transarterial chemoembolization and percutaneous ethanil injection therapy in patients with hepatocellular carcinoma[J].Eur J Gastroenterol Hepatol,1998,11:907.
  • 9[6]YANG JM,YAN YQ,WU MC,et al.Management of regular wound after hepatectomy for primary hepatocellular carcinoma[J].Zhongguo Shiyong Waike Zazhi,1997,17(4):228-229.Chinese
  • 10[7]ZHANG ZJ,WU MC,CHENG H,et al.Treatment of hepatic malignant tumor with radio-frequency heating via percutaneous hepatic puncture[J].Zhonghua Waike Zazhi.2001,39(10):751.Chinese

共引文献56

同被引文献69

引证文献15

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部